1. Management of Antiplatelet Therapy in Patients at Risk for Coronary Stent Thrombosis Undergoing Non-Cardiac Surgery

   • Zuzana Motovska

   Current Opinion 24 September 2012 Pages: 1797 - 1806

   

2. Neuraxial Morphine and Respiratory Depression

   • Pervez Sultan
   • Maria Cristina Gutierrez
   • Brendan Carvalho

   Leading Article 24 September 2012 Pages: 1807 - 1819

   

3. Erratum to: Adult-onset Still’s disease: pathogenesis, clinical manifestations and therapeutic advances

   • A Kontzias
   • R Efthimiou

   Erratum 24 September 2012 Pages: 1820 - 1820

4. Biomarkers of Therapeutic Response in Patients with Chronic Obstructive Pulmonary Disease

   • Ho Il Yoon
   • Don D. Sin

   Review Article 24 September 2012 Pages: 1821 - 1837

   

5. Clinically Significant Drug Interactions with Antacids

   • Ryuichi Ogawa
   • Hirotoshi Echizen

   Review Article 24 September 2012 Pages: 1839 - 1864

   

6. Subcutaneous Recombinant Interferon-β-1a (Rebif®)

   • Mark Sanford
   • Katherine A. Lyseng-Williamson

   Adis Drug Evaluation 24 September 2012 Pages: 1865 - 1891

   

7. Fibrin Sealant (Evicel® [Quixil®/Crosseal™])

   • Sohita Dhillon

   Adis Drug Evaluation 24 September 2012 Pages: 1893 - 1915

   

8. Fenofibrate

   • Kate McKeage
   • Gillian M. Keating

   Adis Drug Evaluation 24 September 2012 Pages: 1917 - 1946